| Sex modifies the APOE‐related risk of developing Alzheimer disease A Altmann, L Tian, VW Henderson, MD Greicius, ... Annals of neurology 75 (4), 563-573, 2014 | 880 | 2014 |
| Discovering statistically significant pathways in expression profiling studies L Tian, SA Greenberg, SW Kong, J Altschuler, IS Kohane, PJ Park Proceedings of the National Academy of Sciences 102 (38), 13544-13549, 2005 | 842 | 2005 |
| Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ... Journal of clinical Oncology 32 (22), 2380-2385, 2014 | 690 | 2014 |
| Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation T Thenappan, SJ Shah, S Rich, L Tian, SL Archer, M Gomberg-Maitland European Respiratory Journal 35 (5), 1079-1087, 2010 | 539 | 2010 |
| The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease T Shirai, RR Nazarewicz, BB Wallis, RE Yanes, R Watanabe, M Hilhorst, ... Journal of Experimental Medicine 213 (3), 337-354, 2016 | 488 | 2016 |
| A simple method for estimating interactions between a treatment and a large number of covariates L Tian, AA Alizadeh, AJ Gentles, R Tibshirani Journal of the American Statistical Association 109 (508), 1517-1532, 2014 | 457 | 2014 |
| Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models H Uno, T Cai, L Tian, LJ Wei Journal of the American Statistical Association 102 (478), 527-537, 2007 | 417 | 2007 |
| Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease DM Lloyd-Jones, K Liu, L Tian, P Greenland Annals of internal medicine 145 (1), 35-42, 2006 | 404 | 2006 |
| A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data H Uno, L Tian, T Cai, IS Kohane, LJ Wei Statistics in medicine 32 (14), 2430-2442, 2013 | 362 | 2013 |
| Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial MM McDermott, K Liu, JM Guralnik, MH Criqui, B Spring, L Tian, ... Jama 310 (1), 57-65, 2013 | 329 | 2013 |
| Physical activity during daily life and mortality in patients with peripheral arterial disease PK Garg, L Tian, MH Criqui, K Liu, L Ferrucci, JM Guralnik, J Tan, ... Circulation 114 (3), 242-248, 2006 | 311 | 2006 |
| Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication MM McDermott, JM Guralnik, L Ferrucci, L Tian, K Liu, Y Liao, D Green, ... Circulation 117 (19), 2484-2491, 2008 | 309* | 2008 |
| On the Cox model with time-varying regression coefficients L Tian, D Zucker, LJ Wei Journal of the American statistical Association 100 (469), 172-183, 2005 | 302 | 2005 |
| AKI in hospitalized children: epidemiology and clinical associations in a national cohort SM Sutherland, J Ji, FH Sheikhi, E Widen, L Tian, SR Alexander, XB Ling Clinical journal of the American Society of Nephrology 8 (10), 1661-1669, 2013 | 292 | 2013 |
| Analysis of randomized comparative clinical trial data for personalized treatment selections T Cai, L Tian, PH Wong, LJ Wei Biostatistics 12 (2), 270-282, 2011 | 285 | 2011 |
| Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis Z Yang, Y Shen, H Oishi, EL Matteson, L Tian, JJ Goronzy, CM Weyand Science translational medicine 8 (331), 331ra38-331ra38, 2016 | 261 | 2016 |
| Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study) MM McDermott, JM Guralnik, L Tian, K Liu, L Ferrucci, Y Liao, L Sharma, ... Journal of the American College of Cardiology 53 (12), 1056-1062, 2009 | 261 | 2009 |
| On the restricted mean survival time curve in survival analysis L Zhao, B Claggett, L Tian, H Uno, MA Pfeffer, SD Solomon, L Trippa, ... Biometrics 72 (1), 215-221, 2016 | 257 | 2016 |
| Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio K Pak, H Uno, DH Kim, L Tian, RC Kane, M Takeuchi, H Fu, B Claggett, ... JAMA oncology 3 (12), 1692-1696, 2017 | 236 | 2017 |
| Effectively selecting a target population for a future comparative study L Zhao, L Tian, T Cai, B Claggett, LJ Wei Journal of the American Statistical Association 108 (502), 527-539, 2013 | 234 | 2013 |
Mary M. McDermottJeremiah Stamler Professor of Medicine, Northwestern UniversityEmail verificata su northwestern.edu